Activated partial thromboplastin time (APTT) clot waveform analysis (CWA) on SYSMEX CS 2000 helps differentiate milder from severe phenotype in patients with severe hemophilia A

被引:0
|
作者
Nair, S. C. [1 ]
Vijay, R. [1 ]
Margaret, H. F. [1 ]
Abraham, A. [2 ]
Vishwabandya, A. [2 ]
Sundarsingh, A. J. [2 ]
Kavitha, M. L. [2 ]
Nobuo, A. [3 ]
Tavkar, P. [3 ]
Hiroshi, K. [3 ]
Srivastava, A. [2 ]
机构
[1] Christian Med Coll Vellore, Transfus Med, Vellore, Tamil Nadu, India
[2] Christian Med Coll Vellore, Haematol, Vellore, Tamil Nadu, India
[3] Sysmex Corp, Kobe, Hyogo, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO153-WED
引用
收藏
页码:808 / 808
页数:1
相关论文
共 10 条
  • [1] Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis
    Kato, Konami
    Hatayama, Yuki
    Shimohiro, Hisashi
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. YONAGO ACTA MEDICA, 2022, 65 (03) : 226 - 230
  • [2] DIFFERENCES IN THE COMPOSITION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) REAGENTS AFFECT CLOT WAVEFORM ANALYSIS
    Kato, Konami
    Hatayama, Yuki
    Shimohiro, Hisashi
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 81 - 82
  • [3] The activated partial thromboplastin time-clot waveform analysis in hemophilia: Does it help in differentiation?
    Mannan, Khalid Abdul
    Kumar, Narender
    Ahluwalia, Jasmina
    Hans, Chander
    Kler, Anita
    Prakash, Gaurav
    Jain, Richa
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (02) : 241 - 249
  • [4] Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A
    Dave, Rutvi G.
    Geevar, Tulasi
    Mammen, Joy J.
    Vijayan, Ramya
    Mahasampath, Gowri
    Nair, Sukesh C.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (01) : 117 - 122
  • [5] The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia a patients with very low levels of factor VIII activity (FVIII:C)
    Shima, M
    Matsumoto, T
    Fukuda, K
    Kubota, Y
    Tanaka, I
    Nishiya, K
    Giles, AR
    Yoshioka, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (03) : 436 - 441
  • [6] Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B
    Atsuko Nishiyama
    Kenichi Ogiwara
    Kuniyoshi Mizumachi
    Naoki Hashimoto
    Masahiro Takeyama
    Keiji Nogami
    [J]. International Journal of Hematology, 2022, 116 : 778 - 786
  • [7] Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B
    Nishiyama, Atsuko
    Ogiwara, Kenichi
    Mizumachi, Kuniyoshi
    Hashimoto, Naoki
    Takeyama, Masahiro
    Nogami, Keiji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (05) : 778 - 786
  • [8] A NOVEL METHOD TO DIFFERENTIATE PLASMA SAMPLES FROM PATIENTS TREATED WITH EMICIZUMAB PROPHYLAXIS USING ACTIVATED PARTIAL THROMBOPLASTIN TIME-BASED CLOT WAVEFORM ANALYSIS
    Maeda, Yuka
    Shimonishi, Naruto
    Ogiwara, Kenichi
    Onishi, Kengo
    Kawabe, Toshiki
    Nishio, Tomohisa
    Nogami, Keiji
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 75 - 75
  • [9] Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis
    Maeda, Koki
    Wada, Hideo
    Shinkai, Toru
    Tanemura, Akihiro
    Matsumoto, Takeshi
    Mizuno, Shugo
    [J]. THROMBOSIS RESEARCH, 2021, 201 : 154 - 160
  • [10] Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A
    Matsumoto, T.
    Nogami, K.
    Tabuchi, Y.
    Yada, K.
    Ogiwara, K.
    Kurono, H.
    Arai, N.
    Shima, M.
    [J]. HAEMOPHILIA, 2017, 23 (05) : e427 - e435